Patents by Inventor Sara Shalin

Sara Shalin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11561224
    Abstract: The invention generally relates to methods for predicting responsiveness of a cancer to an immunotherapeutic agent and methods of treating cancer. More specifically, the invention relates in part to the use of histone H3 lysine (27) trimethylation (H3K27me3), E-cadherin, and other biomarkers to treat cancer and determine the responsiveness of a cancer tumor to treatment with an immunotherapeutic agent.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: January 24, 2023
    Assignee: BIOVENTURES, LLC
    Inventors: Bradley Shields, Alan Tackett, Stephanie Byrum, Fade Mahmoud, Sara Shalin
  • Publication number: 20190346446
    Abstract: The invention generally relates to methods for predicting responsiveness of a cancer to an immunotherapeutic agent and methods of treating cancer. More specifically, the invention relates in part to the use of histone H3 lysine (27) trimethylation (H3K27me3), E-cadherin, and other biomarkers to treat cancer and determine the responsiveness of a cancer tumor to treatment with an immunotherapeutic agent.
    Type: Application
    Filed: February 6, 2018
    Publication date: November 14, 2019
    Applicant: BIOVENTURES, LLC
    Inventors: Bradley Shields, Alan Tackett, Stephanie Byrum, Fade Mahmoud, Sara Shalin